EX-99.1 3 fy15168-kbbrecastex991.htm EXHIBIT 99.1 REVISED SELECTED FINANCIAL DATA Exhibit

EXHIBIT (99.1) Revised Selected Financial Data
The information required by this item is incorporated by reference to Note 1 and Note 12 to our Consolidated Financial Statements.
Financial Summary (Unaudited)
Amounts in millions, except per share amounts
2015 (2)
 
2014
 
2013
 
2012
 
2011
 
2010
Net sales
$
70,749

 
$
74,401

 
$
73,910

 
$
73,138

 
$
70,464

 
$
66,810

Gross profit
33,693

 
35,371

 
35,858

 
35,254

 
35,110

 
34,263

Operating income
11,049

 
13,910

 
13,051

 
12,495

 
13,849

 
14,001

Net earnings from continuing operations
8,287

 
10,658

 
10,346

 
8,864

 
10,509

 
9,635

Net earnings/(loss) from discontinued operations
(1,143
)
 
1,127

 
1,056

 
2,040

 
1,418

 
3,211

Net earnings attributable to Procter & Gamble
7,036

 
11,643

 
11,312

 
10,756

 
11,797

 
12,736

Net earnings margin from continuing operations
11.7
%
 
14.3
%
 
14.0
%
 
12.1
%
 
14.9
%
 
14.4
%
Basic net earnings per common share: (1)
 
 
 
 
 
 
 
 
 
 
 
Earnings from continuing operations
$
2.92

 
$
3.78

 
$
3.65

 
$
3.08

 
$
3.62

 
$
3.21

Earnings/(loss) from discontinued operations
(0.42
)
 
0.41

 
0.39

 
0.74

 
0.50

 
1.11

Basic net earnings per common share
$
2.50

 
$
4.19

 
$
4.04

 
$
3.82

 
$
4.12

 
$
4.32

Diluted net earnings per common share: (1)
 
 
 
 
 
 
 
 
 
 
 
Earnings from continuing operations
$
2.84

 
$
3.63

 
$
3.50

 
$
2.97

 
$
3.46

 
$
3.08

Earnings/(loss) from discontinued operations
(0.40
)
 
0.38

 
0.36

 
0.69

 
0.47

 
1.03

Diluted net earnings per common share
$
2.44

 
$
4.01

 
$
3.86

 
$
3.66

 
$
3.93

 
$
4.11

Dividends per common share
$
2.59

 
$
2.45

 
$
2.29

 
$
2.14

 
$
1.97

 
$
1.80

Research and development expense
$
1,991

 
$
1,910

 
$
1,867

 
$
1,874

 
$
1,812

 
$
1,733

Advertising expense
7,180

 
7,867

 
8,188

 
7,839

 
7,713

 
7,060

Total assets
129,495

 
144,266

 
139,263

 
132,244

 
138,354

 
128,172

Capital expenditures
3,736

 
3,848

 
4,008

 
3,964

 
3,306

 
3,067

Long-term debt
18,327

 
19,807

 
19,111

 
21,080

 
22,033

 
21,360

Shareholders' equity
63,050

 
69,976

 
68,709

 
64,035

 
68,001

 
61,439

(1) 
Basic net earnings per common share and diluted net earnings per common share are calculated based on net earnings attributable to Procter & Gamble.
(2) 
Our 2015 net sales were negatively impacted by approximately $4.4 billion of unfavorable foreign exchange fluctuation compared to 2014. Net earnings attributable to Procter & Gamble in 2015 were negatively impacted by approximately $1.4 billion due to foreign exchange, $2.1 billion of non-cash impairment charges related to the Batteries business reported in discontinued operations and a $2.1 billion Venezuelan deconsolidation charge. These impacts are discussed more fully in "Summary of 2015 Results" and "Results of Operations" of the MD&A (Exhibit 99.2).